Insights

Strategic Partnerships Terumo BCT actively engages with biotherapeutics and CGT developers, recently collaborating with Steminent Biotherapeutics and other clinical-stage CGT players. This indicates a sales opportunity to position compatible manufacturing workflows, automation, and connectivity solutions tailored for cell therapy and regenerative medicine.

Expansion in CGT The company is launching Asia-Pacific CGT ecosystem initiatives and partnering with CGT-focused firms, signaling growing demand for scalable production technologies and regional support. This creates cross-border sales potential for automation, workflow optimization, and regulatory-compliant systems.

Integrated Tech Stack Terumo BCT uses a broad tech stack including Workday, Azure API Management, Salesforce Experience Cloud, SAP WMS, and Boomi, reflecting a mature enterprise with digital integration needs. Opportunities exist to upsell interoperability solutions, data analytics, and cloud-based process automation for manufacturing and clinical workflows.

Global Reach With operations serving over 160 countries and a substantial revenue base, Terumo BCT offers a large, multinational purchasing footprint. Focused outreach can target regional procurement teams with tailored demos of scalable production workflows and cost-of-goods improvements.

Recent Collaborations Recent news highlights collaborations and integrations with StafaCT for device connectivity, and partnerships in MSC therapy manufacturing. This points to a demand for systems integration, device connectivity, and standardized CGT manufacturing processes to accelerate clinical-to-commercial transitions.

Terumo Blood and Cell Technologies Tech Stack

Terumo Blood and Cell Technologies uses 8 technology products and services including Workday Adaptive Planning, Azure API Management, Adobe Animate, and more. Explore Terumo Blood and Cell Technologies's tech stack below.

  • Workday Adaptive Planning
    Accounting And Finance
  • Azure API Management
    Api Management
  • Adobe Animate
    Audio, Video, Graphics
  • Salesforce Experience Cloud
    Customer Relationship Management
  • Artifactory
    Development
  • Windows 10
    Operating Systems
  • Boomi
    Platform As A Service
  • SAP Extended Warehouse Management
    Warehouse Management

Media & News

Terumo Blood and Cell Technologies's Email Address Formats

Terumo Blood and Cell Technologies uses at least 1 format(s):
Terumo Blood and Cell Technologies Email FormatsExamplePercentage
First.Last@terumobct.comJohn.Doe@terumobct.com
95%
FirstLast@terumobct.comJohnDoe@terumobct.com
2%
First.Middle@terumobct.comJohn.Michael@terumobct.com
2%
First@terumobct.comJohn@terumobct.com
1%

Frequently Asked Questions

What is Terumo Blood and Cell Technologies's phone number?

Minus sign iconPlus sign icon
You can contact Terumo Blood and Cell Technologies's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Terumo Blood and Cell Technologies's official website and social media links?

Minus sign iconPlus sign icon
Terumo Blood and Cell Technologies's official website is terumobct.com and has social profiles on LinkedIn.

What is Terumo Blood and Cell Technologies's NAICS code?

Minus sign iconPlus sign icon
Terumo Blood and Cell Technologies's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Terumo Blood and Cell Technologies have currently?

Minus sign iconPlus sign icon
As of July 2026, Terumo Blood and Cell Technologies has approximately 3.7K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Vice President Global Supply Chain: P. S.Vice President Operations: A. M.Vp Manufacturing (regional): M. C.. Explore Terumo Blood and Cell Technologies's employee directory with LeadIQ.

What industry does Terumo Blood and Cell Technologies belong to?

Minus sign iconPlus sign icon
Terumo Blood and Cell Technologies operates in the Medical Equipment Manufacturing industry.

What technology does Terumo Blood and Cell Technologies use?

Minus sign iconPlus sign icon
Terumo Blood and Cell Technologies's tech stack includes Workday Adaptive PlanningAzure API ManagementAdobe AnimateSalesforce Experience CloudArtifactoryWindows 10BoomiSAP Extended Warehouse Management.

What is Terumo Blood and Cell Technologies's email format?

Minus sign iconPlus sign icon
Terumo Blood and Cell Technologies's email format typically follows the pattern of First.Last@terumobct.com. Find more Terumo Blood and Cell Technologies email formats with LeadIQ.

When was Terumo Blood and Cell Technologies founded?

Minus sign iconPlus sign icon
Terumo Blood and Cell Technologies was founded in 1964.
Terumo Blood and Cell Technologies logo

Terumo Blood and Cell Technologies

Medical Equipment ManufacturingColorado, United States1001-5000 Employees

Terumo BCT is a medical equipment manufacturer headquartered in Lakewood, Colorado, at 11158 West Collins Avenue, 80215 United States. The company focuses on blood component processing, therapeutic apheresis and cellular technologies, and is described as providing a unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction, serving customers in more than 160 countries. The business traces its history to 1964, when it was established as COBE Laboratories, and it operates as part of the Terumo BCT organization with global reach. The organization lists between 1,001 and 5,000 employees, indicating a mid-to-large scale operation. Reported annual revenue is in the range of $500 million to $1 billion.

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
1964
Employees
1001-5000

Section iconFunding & Financials

  • $500M$1B

    Terumo Blood and Cell Technologies's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    Terumo Blood and Cell Technologies's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.